Articles:
- SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans
- Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
- Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion
- Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency
- Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
- The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
- A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
- Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease
- Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together
- Considerations for the feasibility of neutralizing antibodies as a surrogate endpoint for COVID-19 vaccines
- Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis
- Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
Fuente: Frontiers in inmunology
